May 10, 2012
GENFIT: GFT505 promotes liver fibrosis regression
May 4, 2012
GFT505 : Strong efficacy with no adverse effects at a dose three-fold higher than the current therapeutic dose (GFT505-111-7 Study)
June 18-21, 2012Boston - USA
November 12-14, 2012Hamburg - Germany
